Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and more

Check out the companies making the biggest moves in premarket trading: Eli Lilly , ResMed — Eli Lilly's stock moved 2% higher following the pharmaceutical giant's announcement that its weight loss drug Zepbound showed the potential to treat patients with obstructive sleep apnea. Shares of ResMed, which makes devices to treat the sleep-related breathing disorder, tumbled nearly 4% on the news.

Holding — U.S.-listed shares sank 5% after the Dutch semiconductor company posted revenue and new bookings that came in below consensus estimates. Urban Outfitters — Shares of the retail company fell 5% after a downgrade to underperform from hold by Jefferies. The investment firm said that foot traffic growth appears to be slowing at Urban Outfitter's branded stores.

ASML Holding NV ASML Holding NV Regwall-Marketmovers Market Insider Markets Economy Business Eli Lilly And Co Stock Markets Breaking News: Markets Resmed Inc Travelers Companies Inc Omnicom Group Inc J.B. Hunt Transport Services Inc United Airlines Holdings Inc Autodesk Inc Alcoa Corp Elf Beauty Inc Ferrari NV Abbott Laboratories Capri Holdings Ltd Urban Outfitters Inc Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly warns 2 of its insulin products may be out of stockThe shortage applies to the company's 10 mL vials of Humalog and Insulin Lispro Injection medications.
Source: 10News - 🏆 732. / 50 Read more »

Eli Lilly Warns That 2 Insulin Products Will Be in Short SupplyDrugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Source: MedicineNet - 🏆 575. / 51 Read more »

Costco Offers Weight Loss Program with Medications from Eli Lilly and Novo NordiskCostco partners with Sesame to provide a weight loss program to members, offering medications like Ozempic and Wegovy. Members can receive three months of clinical consultation and other services for $179.
Source: FoxBusiness - 🏆 458. / 53 Read more »

Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Eli Lilly's Zepbound shows promise as a sleep apnea treatment in late-stage trialsThe pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year. 
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »

Mixed Performance in Asian Stocks as Japanese Markets Rebound, Chinese Stocks FallAsian stocks were a mixed bag on Monday as Japanese markets rebounded from sharp losses seen last week, while Chinese stocks fell amid renewed concerns over the country’s property market.
Source: Investingcom - 🏆 450. / 53 Read more »